Tag: Pharma

Prime Minister, Narendra Modi has asked the pharma industry to work on the manufacture of RNA Testing Kits for COVID-19 on a war footing. He also expressed commitment over maintaining the supply of APIs and manufacture within the country...............

As per the Union Minister for Chemicals and Fertilizers, V Sadananda Gowda, the preparedness of Government, hospitals, medical institutions and pharma sector to deal with Coronavirus in any eventuality have been strong and firmed up..................

Exploring the potential to repurpose marketed products and molecules, the company is developing Anti-SARS-CoV-2 polyclonal hyperimmune globulin (H-IG) to treat infected, high-risk individuals with COVID-19...................

Proven leader with more than 20 years of experience in the biopharmaceutical industry, Dr Mahender Nayak will continue to increase patient access to Takeda’s portfolio of highly innovative medicines..................

In Asia Pacific, this growth would get backed by changing market scenario in countries like India, China, Australia, Japan, South Korea, and others. Investments for such industries are on the rise in these countries....................

Mr Rehan A. Khan has been appointed as the Managing Director of MSD India. He will be assuming responsibility from January 13, 2020....................

Domestic pharma cos expected to grow at a CAGR of around 10-12% between FY2019-2022. The productivity of R&D expenditure, operational risk related to an increased level of due diligence by regulatory agencies and price controls are key concerns................

A new chapter of the widely appreciated India Pharma Week by Informa Markets in India concurrently began at the India Expo Centre, Greater Noida..............  

Discovery marks the first time a new subtype of HIV-1 has been identified since 2000. Abbott is making this new strain accessible to the research community to evaluate its impact to diagnostic testing, treatments and potential vaccines...............

Non-profit product development partnership and generic manufacturer agree to produce new TB drug for countries with high incidence of TB.....................